We demonstrated that CLL patients experience a progressive big ET-1 increase in plasma during the natural disease progression from MBL condition to CLL diagnosis and further when uncontrolled CLL cell accumulation needs therapeutic intervention. The gene discussed is EDN1; the disease is B-cell chronic lymphocytic leukemia.